TL;DR: Persist AI is a Y Combinator Winter 2023 startup Developing long-lasting drug formulations 50% faster, currently active with a team of 6.
Developing long-lasting drug formulations 50% faster
Last verified:
It takes 5 years for pharma to develop long lasting drug injections for chronic diseases like cancer and diabetes. Persist uses AI-driven automation to reduce formulation development time down to 2 years, a ~50% reduction.
Built by LemStudio
Yes. Persist AI was funded by Y Combinator in the Winter 2023 batch. Developing long-lasting drug formulations 50% faster
It takes 5 years for pharma to develop long lasting drug injections for chronic diseases like cancer and diabetes. Persist uses AI-driven automation to reduce formulation development time down to 2 years, a ~50% reduction.
Persist AI was part of Y Combinator's Winter 2023 batch.
Persist AI has a team of 6 people according to Y Combinator's directory.
Persist AI is currently listed as Active with a team of 6 in Y Combinator's directory.
Loading interactive view…